BioPharmX Corp.
(NYSE Amex Equities : BPMX)

( )
BPMX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Producer Manufacturing » Miscellaneous Manufacturing
symbolcompany%chnglast%shortavg$volume
MTDMettler-Toledo International Inc.
-1.49%723.245.3%$90.07m
PNRPentair plc
1.14%38.072.8%$88.89m
DOVDover Corporation
1.30%97.601.3%$87.74m
AMEAMETEK, Inc.
0.76%87.282.1%$75.70m
CSLCarlisle Companies Incorporated
6.64%137.013.7%$47.22m
VMIValmont Industries, Inc.
-0.99%131.191.2%$20.16m
CRCrane Co.
0.53%88.130.6%$16.00m
BRCBrady Corporation Class A
1.50%48.750.9%$9.46m
HIHillenbrand, Inc.
1.08%43.022.0%$7.23m
WMSAdvanced Drainage Systems Inc
0.11%27.148.0%$5.68m
RAVNRaven Industries, Inc.
1.57%39.491.3%$4.74m
TRSTriMas Corporation
0.87%32.561.1%$4.41m
SXIStandex International Corporation
1.41%75.421.4%$3.59m
LXFRLuxfer Holdings PLC Sponsored ADR
-0.64%25.000.0%$3.51m
TGTredegar Corporation
1.79%18.180.9%$1.86m

Company Profile

BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Menlo Park, CA.